Introduction
The grieving process has 4 different aspects: anticipatory grief, acute grief, normal grief reactions and complicated grief. The death of a close loved one remains one of the most intense, distressing, and traumatic events a person may experience (Shear et al. Reference Shear, Frank and Houck2005). Confronted with imminent loss, families experience an emotional burden that includes feelings of helplessness, compassion fatigue, anxiety, and depression, with a strong tendency to stay close to their loved one and provide overprotection. These manifestations are part of the anticipatory grief phenomenon with the anticipation of the future trauma due to loss representation in advance (Coelho and Barbosa Reference Coelho and Barbosa2017). Bereavement can be considered as a continuum from pre-loss to post-loss reactions (Grassi Reference Grassi2007). Bereavement is an existential condition; in some cases, prolonged grief (PG) may occur, the consequences of which may jeopardize quality of life, job conditions, or social relationships, for months, or even years after the loss (Jacobs and Ostfeld Reference Jacobs and Ostfeld1997). Most of the bereaved individuals are able to get adjusted rather quickly, emotional consequences resolve in few months, and pre-loss functioning is restored after a variable period of 6 to 12 months (Prigerson et al. Reference Prigerson, Horowitz and Jacobs2009). However, some people may experience prolonged or complicated grief, with emotional, behavioral, and cognitive symptoms (yearning, searching, detachment, numbness, bitterness, emptiness, and loss of sense and control) (Simon Reference Simon2013). These symptoms may result in a mental illness that is distinct from depression, anxiety, or post-traumatic stress disorders symptoms (Shear et al. Reference Shear, Ghesquiere and Glickman2013) and impaired quality of life. PG has been associated with negative outcomes, such as heart disease or changes in eating (Prigerson et al. Reference Prigerson, Bierhals and Kasl1997) and suicidal ideation (Prigerson et al. Reference Prigerson, Bridge and Maciejewski1999).
PG reactions at 8 months were reported in 24.4% (Chiu et al. Reference Chiu, Huang and Yin2010) and at 6 months in 25.4% (Newson et al. Reference Newson, Boelen and Hek2011), 28.6% (Coelho et al. Reference Coelho, Delalibera and Barbosa2015), 30% (Wiese et al. Reference Wiese, Morgenthal and Bartels2010), and 40% (Guldin et al. Reference Guldin, Vedsted and Zachariae2012) of relatives of a heterogeneous population of patients with cancer. Common factors that complicated grief included pre-loss risk factors (female gender, preexisting trauma such as childhood trauma, prior loss, insecure attachment, preexisting mood and anxiety disorders, and nature of the relationships) (Fujisawa et al. Reference Fujisawa, Miyashita and Nakajima2010; Kersting et al. Reference Kersting, Brahler and Glaesmer2011; Newson et al. Reference Newson, Boelen and Hek2011), loss-related factors (relationships of caregivers taking roles and nature of the death itself) (Fujisawa et al. Reference Fujisawa, Miyashita and Nakajima2010; Neria et al. Reference Neria, Gross and Litz2007; Newson et al. Reference Newson, Boelen and Hek2011), and peri-loss factors (social circumstances, resources available after death, poor understanding of the circumstances of death, interference between natural healing process, and culture practices of death) (Bui et al. Reference Bui, Simon and Robinaugh2013; Hargrave et al. Reference Hargrave, Leathem and Long2012; Mutabaruka et al. Reference Mutabaruka, Sejourne and Bui2012). Although complicated grief decreases over time, its expression varies greatly between individuals, circumstances of death, and culture. Few studies investigated PG reactions in France (Fasse et al. Reference Fasse, Flahault and Bredart2015); specifically, depression was reported in 25% of spouses of palliative cancer patients between 1 and 6 months after death (Fasse et al. Reference Fasse, Flahault and Bredart2015).
To bridge this gap, we investigated the incidence and risk factors of PG in a large population of relatives of patients who died in a palliative care unit.
Methods
Study design
This was a prospective multicenter cohort study in 26 French palliative care units. Written inform consent was obtained from both patients and their relatives. Written inform consent was obtained from each relative of patient admitted in the palliative care unit within the first 48 hours of admission. For patients able to make decision, inform consent was obtained directly from the patient, and in other cases, from their surrogate or other relative member if the patient had no surrogate. The trial protocol has been published in Garrouste-Orgeas et al. (Reference Garrouste-Orgeas, Flahault and Poulain2019a). The statistical plan is available in Supplement 1.
Setting
Palliative care units from the French Association of Palliative Care (SFAP) were invited to participate in the study by mail. Participating units were required to have ≥10 beds and a physician or a nurse or a psychologist who would take responsibility for the study organization and inclusions of relatives and patients. Palliative care units recruited patients from January 2019 to February 2020 (e-Table S1 in Supplement 2). Follow-up was completed in August 2020.
Participants
Inclusion criteria
Consecutive patients with cancer and their relatives admitted in the palliative care unit were approached by physicians or psychologists or nurses. Eligible patients had to be aged at least 18 years to be hospitalized for more than 72 hours for end-of-life issues and to have at least one relative present during the inclusion period and able to visit the patient during the palliative stay. The study was proposed to all relatives present at admission because grief reactions are unique to each relative. The prognostication of end of life was left to the discretion of the physician who examined the patient at admission. Both patients and relatives had to have sufficient French language skills for follow-up telephone interviews. The inclusion period was within 48 hours after palliative care admission.
Exclusion criteria
Patients were ineligible if they had no relatives visiting them during the inclusion period, were under legal guardianship, if their status was considered by the investigator as highly likely to lead to death before 72 hours after admission, if they were not hospitalized for end-of-life issues, and if they had no cancer. Relatives who were mute or deaf or included in another trial with a telephone interview after patient death were also excluded.
Data collection and outcomes
We collected data from centers, patients, and relatives (Supplement 1). Outcomes were measured by 2 psychologists specifically hired for the study (MS and MAL) during telephone interviews conducted 6 months after patient’s death. A relative was declared lost to follow-up if he or she could not be contacted by phone after 7 phone calls at different times of the day.
Primary outcome
The primary outcome was the incidence of PG, measured by the Inventory Complicated Grief (ICG) (Zisook et al. Reference Zisook, Reynolds and Pies2010a, Reference Zisook, Simon and Reynolds2010b) of relatives 6 months after the patient’s death in a palliative care unit. Significant PG symptoms were defined by an ICG > 25 (range 0–76, higher scores indicate more severe symptoms). No minimal clinically significant difference was reported for the ICG.
Prespecified secondary outcomes
Anxiety and depression syndrome were evaluated based on the Hospital Anxiety and Depression Scale (HADS) score (Zigmond and Snaith Reference Zigmond and Snaith1983) (range 0 [best]–42 [worst]). Significant anxiety and depression symptoms were defined by a score >8 for anxiety and depression subscales. The minimal clinically important difference is 2.5 for each subscale (Chan et al. Reference Chan, Aronson Friedman and Bienvenu2016). The evaluation was performed in relatives at Day 3 to Day 5 after patient admission and 6 months after patient’s death.
Post-traumatic stress disorder symptoms were evaluated in relatives at 6 months after patient’s death, through the Impact Event Scale-Revised (IES-R) questionnaire (Rash et al. Reference Rash, Coffey and Baschnagel2008), with significant symptoms defined as an IES-R score >22 (range 0–88, higher score indicates more severe symptoms) (de Miranda et al. Reference de Miranda, Pochard and Chaize2011; Garrouste-Orgeas et al. Reference Garrouste-Orgeas, Flahault and Vinatier2019b). There is no minimal clinically significant difference reported for the IES-R score. We reported scores in the 3 domains (intrusion, avoidance, and hyper arousal) that make up the IES-R score.
Statistical analysis
Results are reported as the median and interquartile range (IQR) or as counts (%). Categorical variables were compared using Chi-square test, and continuous variables were compared using Mann–Whitney test.
To assess the risk factor of PG, we used univariate mixed logistic regression with random effects on patients and centers. Centers with less than 10 patients were grouped together. The log linearity of all continuous variables was checked. The non-log linear variables were discretized into categorical variables. Nonlinear and medically logical variables with a p < 0.1 were used in a multivariate mixed model with random family and center effect after backward selection.
Anxiety and depression syndrome between Day 3 and Day 5 after patient admission and 6 months after patient’s death and post-traumatic stress disorder symptoms 6 month after patient’s death were investigated using the same methodology.
The confidence intervals were calculated according to a binomial distribution approximated by a normal distribution. Missing values for univariate and multivariate analyses were considered by a simple imputation method if less than 20% of data were missing. Variables with more than 20% of data missing were not used in the analyses.
The relationship between outcomes and period of COVID-19-related lockdown was tested in the analysis. Analyses were performed using SAS 9.4 (SAS, Inc., Cary, NC) software, and 2-sided p < 0.05 was considered statistically significant.
Results
Study population and follow-up
Among the 108 invitations sent out, 17 (15.7%) centers declined participation and 65 (60%) did not answer, leaving 26 (24%) palliatives care centers that participated on the study. Recruitment period is reported in e-Table S1 in Supplement 2. Reasons for nonparticipation were lack of interest in the study (n = 3), no time for the study (n = 3), and fear of inclusion of relatives close to the patient admission (n = 11). Characteristics of the 26 palliatives care units are reported in Table 1. Overall, 609 patients and 854 relatives were assessed for eligibility, and 531 patients and 611 relatives were included. Follow-up at 6 months with full completion of the ICG was obtained in 608/611 (99.5%) relatives (Figure 1). Baseline characteristics of patients and eligible, excluded and included relatives are reported, respectively, in e-Tables S2 and S3 in Supplement 2.
Characteristics of centers
IQR = interquartile range.
a No missing data
b Another follow-up (remembrance ceremony with other grieving family, meeting with a physician, and phone call with a caregiver).
Flow chart of the study.
Primary outcome
Six months after patient’s death, the incidence of relatives with an ICG score greater than 25 was 199/608 (32.7%, 95% CI: 29.0–36.4) (Table 2).
Primary and secondary outcomes among relatives at 6-month follow-up after patient’s death in a palliative care unit
ICG = Inventory Complicated Grief; IQR = interquartile range; HADS = Hospital Anxiety Depression Scale, HAS = Hospital Anxiety Score, HAD = Hospital Depression Score; PTSD = post-traumatic stress disorder.
a Measured using the ICG score (range 0–76, higher scores indicates more severe symptoms).
b Measured using the HADS score (overall range, 0–42; range for anxiety and depression subscales, 0–21; a higher score indicates more severe symptoms).
c Measured using the IES-R score (overall range, 0–88; intrusion range: 0–32; avoidance range: 0–28; hyperarousal range: 0–24; a higher score indicates more severe symptoms).
Prespecified secondary outcomes
Within 3 to 5 days after patient admission, symptoms of anxiety (Hospital Anxiety Score [HAS]) were reported by 381 of 583 (65.4%) relatives. Symptoms of depression (HAD) were reported by 215 of 583 (36.9%) relatives. The incidence of HADS symptoms was 87.5% (95% CI, 84.8–90.2). The median (IQR) HADS anxiety score was 10 (7–13), and the median (IQR) HADS depression score was 7 (4–10) (Table 2). Six months after patient’s death, symptoms of anxiety were reported by 229 of 607 (37.7%) relatives and symptoms of depression by 110 of 607 (18.1%). The incidence of HADS symptoms was 68.7% (95% CI, 65.0–72.4). The median (IQR) HADS anxiety score was 7 (5–10) and the median (IQR) HADS depression score was 4 (2–7). The median (IQR) difference between day 3–5 and 6 months after patient’s death was −4 (–10 to 0). Improvement of HADS anxiety and depression scores was reported by 362 of 579 (62.5%) of relatives (Table 2).
The number of patients with an IES-R score greater than 22 was 323/607 (53.2%) with a median (IQR) score of 24 (13–35) (Table 2).
Univariate and multivariate analyses assessing the risk factors of the increase of an ICG score to greater than 25 in relatives are reported, respectively, in e-Table S4 in Supplement 2 and Table 3. The occurrence of respiratory symptoms on admission (OR 1.68, 95% CI, 1.09–2.6, p = 0.01), being the patient’ spouse (OR 2.85, 95% CI 1.53–5.3, p = 0.001), having a support group for relatives in palliative care unit (OR 5.16, 95% CI, 1.65–16.13, p = 0.005), and suffering from anxiety (OR 2.26, 95% CI, 1.4–3.67, p = 0.001) and depression (OR 1.64, 95% CI, 1.06–2.53, p = 0.02) symptoms shortly after patient admission were significantly associated with an ICG score greater than 25.
Multivariable analysis of the occurrence of prolonged grief in relatives of patients who died in a palliative care unit
CI = confidence interval; OR = odds ratio.
Variables included in the multivariable analysis: Center’s related variables: beds > 15 in palliative care unit, 24 hours visitation policies, family on-site sleep with a dedicated room, authorization for relatives to prepare the body for funerals, organization of an interview with relatives at patient’ death, existence of a support group for relatives during palliative care stay; variables related to patient’s symptoms: age; symptoms of admission: (anxiety/psychological suffering, sepsis, pain, neurologic, and digestif); relatives’ related variables: gender, primary caregiver, relation with the patient, lockdown period in France, presence of anxiety symptoms or presence of depression symptoms between Day 3 and Day 5 after patient admission, on the basis of a p-value <0.1.
a The body preparation for funerals is done by the relatives immediately after death with nurses and nursing assistants (washing and dressing the body for funerals and having the possibility to practice religious rite).
b Lockdown period due to Covid-19 pandemic (in France, from 17 March 2020 to 7 June 2020).
Univariate and multivariate analyses of post-traumatic stress disorder symptoms are reported, respectively, in e-Table S5 in Supplement 2 and Table 4. Patient’s age < 65 years old (OR 2.75, 95% CI, 1.31–5.79, p = 0.008) and between 75 and 65 years (OR 1.99, 95% CI, 1.04–3.79, p = 0.036), anxiety/psychological suffering of the patient on admission (OR 1.63, 95% CI, 1.09–2.42, p = 0.01), being a female for the relative (OR 2.75, 95% CI, 1.81–4.17, p < 0.0001), being the spouse/partner of the patient (OR 3.48, 95%CI 1.92–6.31 p < 0.001), or being the children of the patient (OR 2.05, 95% CI 1.16–3.65, p = 0.014) were independent factors of an IES-R > 22.
Multivariable analysis of the occurrence of post-traumatic stress in relatives of patients died in a palliative care unit
CI = confidence interval; OR = Odds ratio.
a The body preparation for funerals is done by the relatives immediately after death with nurses and nursing assistants (washing and dressing the body for funerals and having the possibility to practice religious rite).
Variables in the multivariable analysis on the basis of a p-value < 0.1 included the following: Center variables: beds > 15 in palliative care unit, 24 hours visitation policies, delivery of a children leaflet, sending a condolence letter, presence of a support group for relatives, possibility of sleeping on site, authorization for relatives to prepare the body for funerals, presence of a mourning follow-up, organization of an interview after patient’ death, delivery of an information leaflet at patient’s death. Patients’ variables (age), symptoms of admission (pain, respiratory, digestive, psychological suffering), cardiac comorbidity, diagnosis of the type of cancer, single patient, presence of advanced directives, designation of a surrogate, and patient’s death after continuous deep sedation. Relatives’ variables: gender, age, relation with the patient, primary caregiver, level of education equal or superior to bachelor, presence of anxiety symptoms between Days 3 and 5 after admission diagnosed by a HAS score >8, presence of depression symptoms diagnosed by a HAD score >8 between Days 3 and 5 after admission.
Univariate and multivariate analyses of anxiety and depression HADS scores between Day 3 and Day 5 after palliative care admission and 6 months after death are reported, respectively, in e-Table S6 in Supplement 2 and Table 5. Presence of patient anxiety/psychological symptoms on admission (OR 1.59, 95 CI 1.04–2.06, p = 0.01) was the only factor independently associated with improvement of HADS symptoms in relatives 6 months after patient’s death.
Multivariable analysis of improvement of HADS score in relatives between Day 3 and Day 5 after admission in the palliative care unit and 6 months after patient’s death
CI = confidence interval; OR = odds ratio.
Variables in the multivariable analysis on the basis of a p-value <0.1 included the following: Center variables: beds > 15 in palliative care unit, 24 hours visitation policies, family on-site sleep in a dedicated room, information of relatives with a formal meeting at patient’s death, sending a condolence letter, presence of a grieving support group after death for relatives, presence of a mourning follow-up, and delivery of an information leaflet at patient’s death. Patients’ variables: single patient, age, duration of the cancer history. Relatives’ variables: primary caregiver, relative gender, level of education equal or superior to bachelor, previous palliative care hospitalization for a close relative, presence at home of a health-care worker or a life support person or support hospital service.
No significant associations were found in the univariates analyses between period of lockdown for COVID-19 in France or not and the different outcomes.
Discussion
This observational multicenter study of the psychological status of relatives 6 months after the death of their loved one in a palliative care unit reported high distress with PG reactions, mainly among spouses and partners. PG reactions were present in one relative out of three, and post-traumatic stress disorder symptoms in one out of two. Patient’s respiratory symptoms at admission and high psychological distress shortly after patient’s admission were significantly associated with PG. Palliative care admission was associated with high incidence of HADS symptoms with an improvement in 62% of them between 3 and 5 days after patient’s admission and 6 months following death.
This study was performed in palliative care units trained in multidisciplinary care with physical, social, psychological, cultural, and spiritual support of patients, in order to provide relief of pain and physical symptoms. Relatives were included in this multisystemic approach by being offered on-site psychological support, possibility of being close to the patient and being assured that relief was being provided to their loved one. This global approach aimed at providing support and help to relatives for this intense, emotional experience.
Our study found that PG reactions were frequent, present in one-third of relatives. This was consistent with the proportion of 37% of PG reaction (Prigerson et al. Reference Prigerson, Horowitz and Jacobs2009). It is important to note than among our relatives, 61.5% were primary caregivers, and this may have overburdened their post-loss experience (Geng et al. Reference Geng, Chuang and Yang2018; Ghesquiere et al. Reference Ghesquiere, Haidar and Shear2011; Grosse et al. Reference Grosse, Treml and Kersting2018). Pre-loss symptoms or attachment issues are crucial in creating a vulnerable status for developing PG reactions. Being the spouse or partner of the patient was an independent risk factor for PG, in line with other studies (Thomas et al. Reference Thomas, Hudson and Trauer2014; van Doorn et al. Reference van Doorn, Kasl and Beery1998). Poor adjustment of spouse/partner to grief derived from elements prior to patient’s death (Fasse et al. Reference Fasse, Sultan and Flahault2014): presence of cognitive and emotional features, caregiving experience (Marwit et al. Reference Marwit, Chibnall and Dougherty2008), symptoms of the patient’s disease (Morita et al. Reference Morita, Akechi and Ikenaga2007), patient’s care and treatments and post-loss factors (perception of cancer in the social network) (Fasse et al. Reference Fasse, Sultan and Flahault2014). Low level of active coping in a sample of spouse/partner was the only significant factor associated of developing PG reactions (Miller et al. Reference Miller, Utz and Supiano2020). Higher levels of inflammatory response were found in the bereaved spouse with severe grief reactions (Fagundes et al. Reference Fagundes, Brown and Chen2019).
Factors of PG were usually explored through the individual relative point of view. Our study added the evaluation of patients and center characteristics. We found that respiratory symptoms in patients at admission were independent factors for PG. Respiratory symptoms can be traumatizing for relatives with fear that the patient may experience a painful death. Ruminating memories of this period can elicit difficulties of coping (Coelho and Barbosa Reference Coelho and Barbosa2017). Pre-loss anxiety or depression symptoms were independent factors of PG, in line with other studies (Ghesquiere et al. Reference Ghesquiere, Shear and Duan2013; Lobb et al. Reference Lobb, Kristjanson and Aoun2010; Nielsen et al. Reference Nielsen, Neergaard and Jensen2017; Tsai et al. Reference Tsai, Prigerson and Li2016). Interestingly, our population of relatives of cancer patients suffered anxiety and depression symptoms at the same prevalence than relatives of intensive care patients measured at similar time points after admission (Pochard et al. Reference Pochard, Darmon and Fassier2005). Admission in palliative care for some relatives might be a violent phenomenon and might be a witness of unpreparedness to the upcoming patient’s death. Screening for emotional distress after palliative care admission could identify relatives at risk of PG reactions and offer them effective interventions starting while the patient is still alive, which may improve their dying experience and facilitate preparedness for the patient’s forthcoming death. However, in contrast with small qualitative studies (Harding et al. Reference Harding, Leam and Pearce2002; Henriksson et al. Reference Henriksson, Benzein and Ternestedt2011; Milberg et al. Reference Milberg, Rydstrand and Helander2005), our study found that the support group for relatives during palliative care stay provided by some palliative centers was not an effective option as it increased the risk of PG. Actually, relatives may prefer a face-to-face interview with a psychologist instead of sharing their difficulties with other relatives. Differences in study methodology (qualitative vs. quantitative approach) and in population included (size of the sample) may explain the conflicting results. It seems important to tailor to the relative’s needs during illness trajectory, knowing that needs vary according to illness trajectory. Relative’s needs were more focused on information, on treatment possibilities and side effects (92.8%), diagnosis (91.6%), testing (91.1%), and physical symptoms (90.9%) following diagnosis of cancer (Ndiok and Ncama Reference Ndiok and Ncama2018). During the late phase of illness, insight into the gravity of the illness, participation in care, knowledge of similar situations in participants, and sense of safety in relation with the patient care became more important needs for relatives (Henriksson and Andershed Reference Henriksson and Andershed2007).
There have been few studies examining the prevalence of post-traumatic stress disorder symptoms in relatives after an expected death in palliative care units (Hirooka et al. Reference Hirooka, Fukahori and Taku2017a, Reference Hirooka, Fukahori and Taku2018b). Given that trauma symptoms may be distinct from PG reactions (Horowitz et al. Reference Horowitz, Siegel and Holen1997) but may be highly interconnected (Hirooka et al. Reference Hirooka, Fukahori and Ozawa2017), we found that 53.2% of relatives had post-traumatic stress disorder symptoms 6 months after patient’s death. Young patient age, psychological suffering in patient on admission, being a female partner, or being a patient’s child were found to be independent factors at risk of having post-traumatic stress disorder symptoms. Being provided the opportunity as relatives to sleep on site in a dedicated room and to contribute to the physical preparation of the body for funerals were independent factors of decreasing post-traumatic stress disorder symptoms. These two factors explained the importance for relatives to have the opportunity of saying properly goodbye and of staying close to their loved one during the important moment of the transition from life to death. Sending a condolence letter is a matter of debate in palliative care (Hayward et al. Reference Hayward, Makinde and Vasudev2016; Porter et al. Reference Porter, Weaver and Snaman2021). Half of our units did it. This study showed no benefit of relatives who received a condolence letter contrasting to other study who reported an increase of post-traumatic stress disorder symptoms in different setting (Kentish-Barnes et al. Reference Kentish-Barnes, Chevret and Champigneulle2017).
Given the results of this study reporting high distress in most relatives 6 months after patient’s death, prevention strategies should be discussed. Although several interventions conducted in outpatient cancer improved relatives’ outcomes while the patient was alive (Dionne-Odom et al. Reference Dionne-Odom, Azuero and Lyons2015a, Reference Dionne-Odom, Azuero and Lyons2016b), conflicting preventive measures were reported in relatives’ bereavement outcomes. A proactive randomized communication intervention to help patients/relatives to ask questions, express concerns, and help oncologist to address them effectively did not significantly improve mental health, anxiety, depression symptoms, or PG reactions 7 months after patient’s death (Duberstein et al. Reference Duberstein, Maciejewski and Epstein2019). A randomized trial including bereaved individuals, at risk for PG, 8 months after loss, reported significant efficacy of a cognitive–behavioral therapist-assisted–internet delivered intervention on PG, anxiety, depression, and PTSD (Litz et al. Reference Litz, Schorr and Delaney2014). Research on internet-based grief therapy is ongoing (Hoffmann et al. Reference Hoffmann, Grosse and Nagl2018). This study contributes data that suggest a profile at high-risk relatives of PG. Screening symptoms suggestive of anxiety and depression shortly after patient admission, taking care of relatives of patients with respiratory symptoms, or psychological suffering might alleviate the burden of relatives. The qualitative part of our study, interviewing relatives with PG, should add insights into the improvement of the bereavement process.
This study has several strengths and limitations. The multicenter design and the high number of included relatives and their high response rate at 6 months provide a large overview of post-loss relatives’ conditions. We chose to include all relatives willing to participate, providing a potentially broad panel of individual consequences according to their relationship with the patient. This study has several limitations. First, only 24% of invited centers participated in the study, mainly due to fear of physicians to include relatives in a bereavement research project, which contrasts with the reportedly beneficial effects of participating in research for bereaved relatives (Kentish-Barnes et al. Reference Kentish-Barnes, McAdam and Kouki2015). However, participating centers were representative of the current practice for family-centered care in France (Rhondali et al. Reference Rhondali, Dev and Barbaret2014). Second, grief is a complex phenomenon, and components of psychological distress may not have been sufficiently taken into account in the different statistical models. Third, this study was performed in France and the results may not be generalizable to other European and non-European culture settings (Avidan et al. Reference Avidan, Sprung and Schefold2021).
Conclusions
Six months after the death of a loved one with cancer in palliative care units in France, one-third of relatives were still suffering of complicated grief and half of them had a post-traumatic stress disorder. No recommendations are currently available to prevent these psychological consequences. Thus, this study represents the first step of a potential process of prevention of PG. The next step in our study, the testimony of relatives who have experienced this trauma, will help to define other improvement strategies.
Supplementary material
The supplementary material for this article can be found at https://doi.org/10.1017/S1478951523000111.
Acknowledgments
This work was supported by the Fondation-de-France (ENG 00089287). The funders did not influence study design, conduct, or reporting. The authors thank Céline Féger, MD (EMIBiotech), for her editorial support. Registration no: NCT03748225.
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical approval
In accordance with French law, the study (2017-A03440-53) was approved by the “Sud-Ouest et Outremer 1” ethics committee on 20 March 2018 and 4 March 2019 and the CNIL (Commission Nationale de l’Informatique et des Libertés; number 918120, on 15 June 2018). In accordance with French law, patient’s data are collected following the criteria of certificate of conformity MR003.
Open access
